[HTML][HTML] Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy

R Dong, M Zhang, Q Hu, S Zheng… - International …, 2018 - spandidos-publications.com
Galectin-3 is a member of the galectin family, which are β‑galactoside‑binding lectins with≥
1 evolutionary conserved carbohydrate‑recognition domain. It binds proteins in a …

[HTML][HTML] Galectin-3: one molecule for an alphabet of diseases, from A to Z

S Sciacchitano, L Lavra, A Morgante, A Ulivieri… - International journal of …, 2018 - mdpi.com
Galectin-3 (Gal-3) regulates basic cellular functions such as cell–cell and cell–matrix
interactions, growth, proliferation, differentiation, and inflammation. It is not surprising …

Pulmonary hypertension in infants, children, and young adults

G Hansmann - Journal of the American College of Cardiology, 2017 - jacc.org
Pulmonary hypertension (PH) in neonates, infants, children, adolescents, and young adults
is a complex condition that can be associated with several cardiac, pulmonary, and systemic …

[HTML][HTML] Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening

SF Liu, N Nambiar Veetil, Q Li… - Frontiers in …, 2022 - frontiersin.org
Pulmonary hypertension (PH) is a progressive disease that arises from multiple etiologies
and ultimately leads to right heart failure as the predominant cause of morbidity and …

Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018

G Kovacs, D Dumitrescu, A Barner, S Greiner… - International journal of …, 2018 - Elsevier
In the summer of 2016, delegates from the German Society of Cardiology (DGK), the
German Respiratory Society (DGP), and the German Society of Pediatric Cardiology (DGPK) …

[HTML][HTML] Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases

P Nangia-Makker, V Hogan, V Balan, A Raz - Journal of Biological …, 2022 - ASBMB
Fibrosis, stiffening and scarring of an organ/tissue due to genetic abnormalities,
environmental factors, infection, and/or injury, is responsible for> 40% of all deaths in the …

NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension

AO Samokhin, T Stephens, BM Wertheim… - Science translational …, 2018 - science.org
Germline mutations involving small mothers against decapentaplegic–transforming growth
factor–β (SMAD–TGF-β) signaling are an important but rare cause of pulmonary arterial …

Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms

J Bauersachs, A Lother - Kidney International Supplements, 2022 - Elsevier
Aldosterone controls salt–water homeostasis by acting on the mineralocorticoid receptor
(MR), a ligand-activated transcription factor, in kidney epithelial cells. However, it is now …

[HTML][HTML] Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension

FT Bekedam, MJ Goumans, HJ Bogaard… - Pharmacology & …, 2023 - Elsevier
Right ventricular fibrosis is a stress response, predominantly mediated by cardiac
fibroblasts. This cell population is sensitive to increased levels of pro-inflammatory …

[HTML][HTML] Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis

SA Barman, X Li, S Haigh… - … of Physiology-Lung …, 2019 - journals.physiology.org
A defining characteristic of pulmonary hypertension (PH) is the extensive remodeling of
pulmonary arteries (PAs), which results in progressive increases in vascular resistance and …